Finance

Beta
Lists
300562:SHE
Guangdong Transtek Medicl Elctrncs CoLtd
CN¥12.06
+1.86%
(+0.22) 1D
Jun 5, 3:04:22 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300562...
Open
CN¥11.85
High
CN¥12.23
Low
CN¥11.80
Mkt. cap
2.64B
Avg. vol.
7.48M
Volume
5.16M
Dividend
2.16%
Quarterly dividend
CN¥0.06
Ex-dividend date
May 14, 2026
P/E ratio
28.87
52-wk high
CN¥17.77
52-wk low
CN¥11.74
EPS
CN¥0.42
Shares outstanding
218.61M
No. of employees
1K
Open
CN¥11.85
High
CN¥12.23
Low
CN¥11.80
Mkt. cap
2.64B
Avg. vol.
7.48M
Volume
5.16M
Dividend
2.16%
Quarterly dividend
CN¥0.06
Ex-dividend date
May 14, 2026
P/E ratio
28.87
52-wk high
CN¥17.77
52-wk low
CN¥11.74
EPS
CN¥0.42
Shares outstanding
218.61M
No. of employees
1K
News stories
From sources across the web
Profile
Transtek Medical, commonly known as Lifesense, fully referred to as Guangdong Transtek Medical Electronics Co., Ltd., is a Chinese wearable device maker that also focuses on the field of mobile health. The company was founded by Weichao Pan in 2002, with its main products being home medical and health electronics, such as scales, smart bracelets and blood pressure monitors. According to IDC, the company shipped one million units of wearables in the second quarter of 2016, ranking fifth in the global wearable devices market, coming in behind Fitbit, Apple and Garmin. Transtek's IPO application was approved by the CSRC in October 2016. On November 16, it landed on the Shenzhen Stock Exchange with the ticker symbol "300562.SZ". Wikipedia
About Guangdong Transtek Medicl Elctrncs CoLtd
CEO-
Employees1.09K
FoundedJul 18, 2002
Headquarters-
SectorMedical device
Websitelifesense.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
248.06M
235.76M
229.08M
283.74M
Cost of goods sold
167.40M
149.14M
152.94M
176.58M
Cost of revenue
167.40M
149.14M
152.94M
176.58M
Research and development expenses
23.61M
20.36M
24.79M
26.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.02M
41.57M
26.45M
41.12M
Operating expense
57.28M
58.96M
52.61M
71.19M
Total operating expenses
224.68M
208.10M
205.55M
247.78M
Operating income
23.38M
27.66M
23.53M
35.96M
Other non operating income
-2.99M
-3.39M
2.22M
-4.58M
EBT including unusual items
20.12M
23.63M
16.59M
32.82M
EBT excluding unusual items
25.22M
25.70M
24.73M
31.68M
Income tax expense
1.65M
118.51K
1.08M
931.10K
Effective tax rate
8.22%
0.50%
6.54%
2.84%
Other operating expenses
2.57M
-1.92M
3.87M
1.19M
Net income
19.35M
23.39M
16.32M
32.07M
Net profit margin
7.80%
9.92%
7.12%
11.30%
Earnings per share
-
-
-
-
Interest and investment income
5.05M
3.39M
2.85M
330.33K
Interest expense
-778.72K
-1.40M
-
-37.02K
Net interest expenses
4.27M
1.99M
2.85M
293.32K
Depreciation and amortization charges
-
-
-
-
EBITDA
27.95M
32.45M
28.29M
40.73M
Gain or loss from assets sale
150.13K
-150.13K
26.11K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer